NEW YORK (GenomeWeb) – A collection of new studies suggest that it may be time to rethink cervical cancer screening methods, moving away from cytology-based testing on Pap smear samples and toward direct screening for DNA from human papillomavirus (HPV).

Because the vast majority of cervical cancer cases can be traced back to persistent HPV infection — particularly infections involving HPV16 or HPV18 types — methods have emerged for directly detecting as a means of identifying individuals at risk of the disease who might require enhanced screening.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.